Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,585,000
+6,000 (0.38%)
Last updated: Mar 10, 2026, 1:21 PM KST

Samsung Biologics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
148,851391,222367,937890,82047,410
Upgrade
Short-Term Investments
1,336,232940,0671,688,3382,204,212473,985
Upgrade
Trading Asset Securities
---98,506850,040
Upgrade
Cash & Short-Term Investments
1,485,0831,331,2892,056,2763,193,5371,371,435
Upgrade
Cash Growth
11.55%-35.26%-35.61%132.86%60.96%
Upgrade
Accounts Receivable
654,728-0--0
Upgrade
Other Receivables
21,739----
Upgrade
Receivables
676,467-0--0
Upgrade
Inventory
2,128,1642,818,2762,641,3682,375,8191,012,871
Upgrade
Prepaid Expenses
14,34928,25126,83023,2018,579
Upgrade
Other Current Assets
104,3041,340,302797,513865,099430,291
Upgrade
Total Current Assets
4,408,3675,518,1185,521,9886,457,6572,823,175
Upgrade
Property, Plant & Equipment
6,037,5325,837,4824,342,4243,871,4522,227,687
Upgrade
Long-Term Investments
78,32559,60547,43538,1102,661,499
Upgrade
Goodwill
-1,677,6081,677,6081,677,608-
Upgrade
Other Intangible Assets
60,1931,294,7051,580,4231,541,85032,172
Upgrade
Long-Term Accounts Receivable
-00-00
Upgrade
Long-Term Deferred Tax Assets
132,837165.09---
Upgrade
Long-Term Deferred Charges
-2,592,9902,574,0572,741,848-
Upgrade
Other Long-Term Assets
343,458355,592302,236253,524225,477
Upgrade
Total Assets
11,060,74217,336,29616,046,19716,582,0507,970,011
Upgrade
Accounts Payable
59,814177,992201,70959,61632,251
Upgrade
Accrued Expenses
314,573545,403281,317207,43774,322
Upgrade
Short-Term Debt
-327,000654,500582,78350,000
Upgrade
Current Portion of Long-Term Debt
319,713-733,405556,017109,855
Upgrade
Current Portion of Leases
7,258138,594144,031142,2477,537
Upgrade
Current Income Taxes Payable
355,700375,388191,212223,299110,174
Upgrade
Current Unearned Revenue
-400,007399,818432,680-
Upgrade
Other Current Liabilities
1,475,8601,888,8041,551,8701,977,462723,156
Upgrade
Total Current Liabilities
2,532,9173,853,1884,157,8614,181,5421,107,295
Upgrade
Long-Term Debt
599,0121,012,757239,783965,0901,114,684
Upgrade
Long-Term Leases
1,1127,889137,614267,89610,671
Upgrade
Pension & Post-Retirement Benefits
-5,5475,117--
Upgrade
Long-Term Deferred Tax Liabilities
-972,0621,184,4201,214,216487,712
Upgrade
Other Long-Term Liabilities
476,590580,177490,910968,833258,547
Upgrade
Total Liabilities
3,609,6316,431,6206,215,7057,597,5762,978,909
Upgrade
Common Stock
115,727177,935177,935177,935165,413
Upgrade
Additional Paid-In Capital
3,391,9265,663,1115,663,1115,663,1112,487,313
Upgrade
Retained Earnings
6,870,9615,086,6094,003,2933,145,6012,347,187
Upgrade
Treasury Stock
-2,907,695----
Upgrade
Comprehensive Income & Other
-19,809-22,979-13,847-2,173-8,811
Upgrade
Shareholders' Equity
7,451,11110,904,6769,830,4928,984,4744,991,102
Upgrade
Total Liabilities & Equity
11,060,74217,336,29616,046,19716,582,0507,970,011
Upgrade
Total Debt
927,0941,486,2391,909,3332,514,0331,292,747
Upgrade
Net Cash (Debt)
557,989-154,951146,943679,50478,688
Upgrade
Net Cash Growth
---78.38%763.54%17.19%
Upgrade
Net Cash Per Share
8326.90-2177.123174.3414965.871828.54
Upgrade
Filing Date Shares Outstanding
129.1746.2946.2946.2943.03
Upgrade
Total Common Shares Outstanding
129.1746.2946.2946.2943.03
Upgrade
Working Capital
1,875,4491,664,9291,364,1272,276,1151,715,881
Upgrade
Book Value Per Share
57685.15235568.21212363.16194087.06115982.76
Upgrade
Tangible Book Value
7,390,9177,932,3636,572,4615,765,0164,958,931
Upgrade
Tangible Book Value Per Share
57219.14171358.83141981.56124538.73115235.15
Upgrade
Land
461,974141,114141,065141,065-
Upgrade
Buildings
3,337,8951,956,9581,943,6941,376,222832,519
Upgrade
Machinery
3,262,1772,629,5982,525,3441,811,9821,380,919
Upgrade
Construction In Progress
430,1611,833,097202,411825,199583,360
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.